Physician profile
Florentina Chirica
NPI 1558685206
$1,219.05
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $367 · 2021: $250 · 2022: $35.63.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $133.20 | 2019-2021 | |
| Pfizer INC. | $120.51 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $113.84 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.63 | 2019-2020 | |
| Novo Nordisk INC | $82.09 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $68.50 | 2019-2021 | |
| Amgen INC. | $66.37 | 2019-2021 | |
| Abbvie INC. | $60.25 | 2019-2021 | |
| Lilly USA, LLC | $53.86 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $39.28 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.71 | 2019-2021 | |
| Daiichi Sankyo INC. | $36.69 | 2019-2020 | |
| Amarin Pharma, INC. | $36.39 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $35.63 | 2022 | |
| Astellas Pharma US INC | $31.32 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $29.09 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.49 | 2019-2020 | |
| Lifescan, INC. | $21.27 | 2019 | |
| Abbott Laboratories | $20.67 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.38 | 2020 | |
| Mannkind Corporation | $16.10 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.91 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.89 | 2021 | |
| Scilex Pharmaceuticals INC. | $15.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $13.21 | 2021 | |
| Glaxosmithkline, LLC. | $12.77 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florentina Chirica listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.